S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NASDAQ:SIBNSI-Bone Stock Price, Forecast & News

$19.43
+1.95 (+11.16 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.53
Now: $19.43
$20.37
50-Day Range
$14.77
MA: $16.44
$17.48
52-Week Range
$7.20
Now: $19.43
$23.10
Volume433,821 shs
Average Volume221,738 shs
Market Capitalization$552.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.30 million
Book Value$2.52 per share

Profitability

Net Income$-38,400,000.00

Miscellaneous

Employees183
Market Cap$552.34 million
Next Earnings Date11/9/2020 (Estimated)
OptionableNot Optionable
$19.43
+1.95 (+11.16 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

How has SI-Bone's stock been impacted by COVID-19 (Coronavirus)?

SI-Bone's stock was trading at $15.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SIBN stock has increased by 26.8% and is now trading at $19.43.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of SI-Bone?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for SI-Bone
.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for SI-Bone
.

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) issued its earnings results on Monday, August, 3rd. The company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.64) by $0.20. SI-Bone had a negative return on equity of 51.33% and a negative net margin of 60.51%.
View SI-Bone's earnings history
.

What price target have analysts set for SIBN?

6 brokers have issued twelve-month target prices for SI-Bone's stock. Their forecasts range from $22.00 to $27.00. On average, they expect SI-Bone's stock price to reach $24.50 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.
View analysts' price targets for SI-Bone
.

Has SI-Bone been receiving favorable news coverage?

News stories about SIBN stock have been trending somewhat positive recently, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. SI-Bone earned a news impact score of 0.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.
View the latest news about SI-Bone
.

Are investors shorting SI-Bone?

SI-Bone saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,010,000 shares, an increase of 54.4% from the June 30th total of 654,100 shares. Based on an average daily trading volume, of 170,300 shares, the short-interest ratio is currently 5.9 days. Currently, 4.7% of the company's stock are short sold.
View SI-Bone's Current Options Chain
.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-Bone investors own include Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO), CSX (CSX), Altria Group (MO) and Procter & Gamble (PG).

Who are SI-Bone's key executives?

SI-Bone's management team includes the following people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Columbus Circle Investors (0.09%), SG Americas Securities LLC (0.05%) and UBS Group AG (0.03%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling.
View institutional ownership trends for SI-Bone
.

Which major investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, and UBS Group AG. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp, and W Carlton Reckling.
View insider buying and selling activity for SI-Bone
.

Which major investors are buying SI-Bone stock?

SIBN stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita, and Skyline Venture Partners V Lp.
View insider buying and selling activity for SI-Bone
.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $19.43.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $552.34 million and generates $67.30 million in revenue each year. The company earns $-38,400,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. SI-Bone employs 183 workers across the globe.

What is SI-Bone's official website?

The official website for SI-Bone is www.si-bone.com.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.